Device-Based Neuromodulation for Resistant Hypertension Therapy.
Ontology highlight
ABSTRACT: Despite availability of effective drugs for hypertension therapy, significant numbers of hypertensive patients fail to achieve recommended blood pressure levels on ≥3 antihypertensive drugs of different classes. These individuals have a high prevalence of adverse cardiovascular events and are defined as having resistant hypertension (RHT) although nonadherence to prescribed antihypertensive medications is common in patients with apparent RHT. Furthermore, apparent and true RHT often display increased sympathetic activity. Based on these findings, technology was developed to treat RHT by suppressing sympathetic activity with electrical stimulation of the carotid baroreflex and catheter-based renal denervation (RDN). Over the last 15 years, experimental and clinical studies have provided bet
SUBMITTER: Lohmeier TE
PROVIDER: S-EPMC6442942 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA